Autopsy report · NCT05030623

The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients

“Institutional and funding constrains”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Sadat City University

Sponsor type

University, hospital or other

Conditions

Major Depressive Disorder

Interventions

Tadalafil 5Mg Tab; Placebo

Participants

0

Sites

1

Countries

Egypt

Trials that died the same way

• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
  “Funding constraints” (79% match in meaning)
• Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement
  “Funding issues” (70% match in meaning)
• Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients
  “Institutional Issue” (70% match in meaning)
• Thrust Versus Non-thrust Manipulation in Chronic Low Back Pain
  “Time and funding constraints” (69% match in meaning)
• Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression
  “Limited funding” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.